Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection.

Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, Zack JA, Detels R, Martínez-Maza O.

J Interferon Cytokine Res. 2005 Nov;25(11):702-6.

PMID:
16318584
2.

Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.

Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A.

Blood. 2008 Dec 1;112(12):4401-10. doi: 10.1182/blood-2008-02-140426. Epub 2008 Sep 9.

3.

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.

Regidor DL, Detels R, Breen EC, Widney DP, Jacobson LP, Palella F, Rinaldo CR, Bream JH, Martínez-Maza O.

AIDS. 2011 Jan 28;25(3):303-14. doi: 10.1097/QAD.0b013e32834273ad.

4.

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.

Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.

J Clin Immunol. 2010 Jan;30(1):45-52. doi: 10.1007/s10875-009-9325-5. Epub 2009 Sep 23.

PMID:
19774453
5.

Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor.

Jenh CH, Cox MA, Hipkin W, Lu T, Pugliese-Sivo C, Gonsiorek W, Chou CC, Narula SK, Zavodny PJ.

Cytokine. 2001 Aug 7;15(3):113-21.

PMID:
11554781
6.

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.

Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, Trevisan C, Taylor J, Detels R, Martínez-Maza O.

Clin Immunol. 1999 Nov;93(2):114-23.

PMID:
10527687
7.

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E.

Brain. 2006 Jan;129(Pt 1):200-11. Epub 2005 Nov 9.

PMID:
16280350
8.

CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.

Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z, Qingping G, Kejian Z, Li Q, Chang AE, Youxin J, Jinquan T.

J Immunol. 2006 Nov 15;177(10):6713-22.

9.

Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.

Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD.

Arthritis Rheum. 2001 Nov;44(11):2633-41.

PMID:
11710719
10.

Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.

Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N.

Ophthalmology. 2003 Feb;110(2):421-6.

PMID:
12578791
12.

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.

Bürkle A, Niedermeier M, Schmitt-Gräff A, Wierda WG, Keating MJ, Burger JA.

Blood. 2007 Nov 1;110(9):3316-25. Epub 2007 Jul 25.

13.

Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.

De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, Zazzi M, Chiodi F.

Clin Exp Immunol. 2002 Mar;127(3):486-94. Erratum in: Clin Exp Immunol. 2003 Oct;134(1):167. D Fuchs [corrected to Fuchs D].

14.

Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13.

Cupedo T, Lund FE, Ngo VN, Randall TD, Jansen W, Greuter MJ, de Waal-Malefyt R, Kraal G, Cyster JG, Mebius RE.

J Immunol. 2004 Oct 15;173(8):4889-96.

16.

Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.

Richard Y, Amiel C, Jeantils V, Mestivier D, Portier A, Dhello G, Feuillard J, Creidy R, Nicolas JC, Raphael M.

J Infect Dis. 2010 Nov 1;202(9):1424-34. doi: 10.1086/656479.

PMID:
20874514
17.

CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.

Litsiou E, Semitekolou M, Galani IE, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S, Tsoumakidou M.

Am J Respir Crit Care Med. 2013 Jun 1;187(11):1194-202. doi: 10.1164/rccm.201208-1543OC.

PMID:
23525932
18.

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, Klein M, Pfister HW, Koedel U.

J Neuroinflammation. 2009 Dec 30;6:42. doi: 10.1186/1742-2094-6-42.

19.

Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, Widney D, Conn D, Sehl M, Jacobson LP, Bream JH, Wolinsky S, Rinaldo CR, Ambinder RF, Detels R, Zhang ZF, Martínez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):295-307. doi: 10.1158/1055-9965.EPI-12-1122. Epub 2012 Dec 18.

20.

Soluble CD27 induces IgG production through activation of antigen-primed B cells.

Dang LV, Nilsson A, Ingelman-Sundberg H, Cagigi A, Gelinck LB, Titanji K, De Milito A, Grutzmeier S, Hedlund J, Kroon FP, Chiodi F.

J Intern Med. 2012 Mar;271(3):282-93. doi: 10.1111/j.1365-2796.2011.02444.x. Epub 2011 Sep 14.

Supplemental Content

Support Center